<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>PROFESSIONAL LIABILITY INSURANCE IN THE MEDICAL BUSINESS: BALANCING  THE INTERESTS OF PATIENTS AND DOCTORS</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Achilova Liliya</mods:namePart><mods:namePart type="family">Achilova Liliya</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Rozmetova Asal</mods:namePart><mods:namePart type="family">Rozmetova Asal</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>This thesis explores professional liability insurance in the medical business as a key mechanism for&#13;
ensuring a balance between the interests of patients and doctors. It examines the legal framework of&#13;
Uzbekistan, including the 2019–2025 Healthcare Development Concept and the draft Law “On&#13;
Medical Practice and Mandatory Professional Liability Insurance for Medical Workers.” Based on&#13;
the analysis of regulatory acts and expert opinions of the National Chamber of Innovative Healthcare,&#13;
the main problems and directions of reform are identified. A comparative legal study of international&#13;
experience (USA, Europe, Scandinavia, New Zealand, and Kazakhstan) demonstrates that an&#13;
effective insurance model should combine guaranteed compensation for patients with the protection&#13;
of doctors from excessive risks and unfounded claims. The study concludes that Uzbekistan’s&#13;
legislation requires improvement, taking into account international models, the development of a&#13;
transparent compensation mechanism, and the possible creation of a state guarantee fund. It is&#13;
emphasized that building an optimal insurance model is a dynamic process requiring continuous&#13;
monitoring and constructive interaction between the state, the medical community, insurers, and&#13;
patients.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2025-10-04</mods:dateIssued></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>